Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coutts

Showing results (211-220 of 256) with videos related to

Pageof 26
Sort By:
Stroke|January 18, 2020
A Risk Score Including Carotid Plaque Inflammation and Stenosis Severity Improves Identification of Recurrent StrokePeter J Kelly, Pol Camps-Renom, Nicola Giannotti, et al.
The Lancet. Neurology|October 12, 2010
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational studyAine Merwick, Gregory W Albers, Pierre Amarenco, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 12, 2020
Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular eventsTheodore Wein, M Patrice Lindsay, David J Gladstone, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2023
Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trialsAnas Alrohimi, David Z Rose, W Scott Burgin, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 6, 2020
Theodore Wein, M Patrice Lindsay, David J Gladstone, et al.
European Stroke Journal|March 12, 2025
Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT TrialSajeevan Sujanthan, Pugaliya Puveendrakumaran, Katie N Dainty, et al.
Journal of Stroke|February 7, 2025
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 TrialMayank Goyal, Bijoy K Menon, Johanna Ospel, et al.
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Stroke and Vascular Neurology|January 31, 2024
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trialRadhika Nair, Nishita Singh, Mahesh Kate, et al.
Pageof 26

Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
Stroke|January 18, 2020
A Risk Score Including Carotid Plaque Inflammation and Stenosis Severity Improves Identification of Recurrent StrokePeter J Kelly, Pol Camps-Renom, Nicola Giannotti, et al.
The Lancet. Neurology|October 12, 2010
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational studyAine Merwick, Gregory W Albers, Pierre Amarenco, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 12, 2020
Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular eventsTheodore Wein, M Patrice Lindsay, David J Gladstone, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2023
Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trialsAnas Alrohimi, David Z Rose, W Scott Burgin, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 6, 2020
Theodore Wein, M Patrice Lindsay, David J Gladstone, et al.
European Stroke Journal|March 12, 2025
Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT TrialSajeevan Sujanthan, Pugaliya Puveendrakumaran, Katie N Dainty, et al.
Journal of Stroke|February 7, 2025
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 TrialMayank Goyal, Bijoy K Menon, Johanna Ospel, et al.
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Stroke and Vascular Neurology|January 31, 2024
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trialRadhika Nair, Nishita Singh, Mahesh Kate, et al.
Pageof 26